Dr. Mohiedean Ghofrani @mghofrani , ABPath Trustee, presents "Reporting Discrete Non-Gynecologic Cytology Diagnoses in Epic Beaker AP Based on Standardized Terminologies" at the Pathology Informatics Summit 2024 - Association of Pathology Informatics.
Another fantastic thread from @smlungpathguy for anyone learning #pathology#histology#cytology#PulmPath For PGY1s remember it is okay to say that you don’t know and learn. This is your moment. So read up, spend time on the microscope, listen and learn🔬 #PathPearls
At 4:30pm today, #CytoPath Legend @NayarRitu will present on the evolution of #CervicalCancer screening at #USCAP2024. Revisit Dr. Nayar's @cervicalRT commentary on the past, present, and future of cervical cancer prevention: https://t.co/JfSNE1CxPO
FANTASTIC testimony by Dr. Dara Aisner on the potential impact of the FDA proposed ruling for LDT in today’s Health Subcommittee Hearing on Regulation of Diagnostic Tests ! Thank you @AMPath staff as well… I c u🫶🏽! Replay here 👉🏽 https://t.co/qGlyDbiTjR
So incredibly proud to know Dara Aisner who gave an incredible testimony at the Health Subcommittee hearing today. Watch it to fully understand the impact of the FDA proposed ruling for lab developed tests #pathology#LDT https://t.co/tN8EvDpgcU Thank you @AMPath
📸 Meet the UTMB Pathology residents! Ready to dive into the world of pathology together🔬🎉 Excited to welcome new faces to our @UTMB_Pathology family this Match Day! 🎊
#PathMatch24#PathTwitter
Hot off the press!
Delighted to share the review article by Jason Chang and I @ModernPathology on the ever-vexing problem of multiple lung carcinomas.
This affects ~1 in 5 patients with lung cancer, so is exceedingly common.
Recent molecular methods are providing major insights into pathology and clinical aspects here.
Please check it out!
https://t.co/ooysVyHWKQ
@PulmPathSoc@MSKPathology #PulmPath #MolPath @DrNetto@smlungpathguy